Bacopa monnieri 'Bacognize'

Bacognize is a standardized extract of Bacopa monnieri delivering a minimum 12% total bacosides and enriched glycosides, primarily bacopaside I, II, and X. It supports cognitive function primarily by modulating serotonin and dopamine receptor activity while inhibiting acetylcholinesterase, enhancing cholinergic neurotransmission.

Origin & History

Bacopa monnieri 'Bacognize' is a proprietary standardized extract derived from the perennial herb Bacopa monnieri (Brahmi), native to wetlands across India, Australia, Africa, and the Americas. This cultivar variant is produced through controlled cultivation and ethanolic or methanolic extraction, yielding standardized levels of bacopa glycosides (primarily bacosides) while maintaining non-GMO verified, clean-label status.

Historical & Cultural Context

Bacopa monnieri (Brahmi) has been used in Ayurvedic medicine as a medhya rasayana, a mind-sharpening nootropic and rejuvenator for cognitive enhancement and intellect. The herb has ancient roots in Indian traditional medicine, though specific duration and traditional preparation methods are not detailed in available sources.

Health Benefits

• Cognitive health support - vendor claims reference 'several clinical studies' on bacopa glycosides, though specific trial data is not provided
• Emotional wellbeing - mentioned in vendor literature but without clinical evidence cited
• Restorative sleep support - claimed benefit lacking specific study references
• Healthy aging properties - based on general antioxidant and neuroprotective effects observed in preclinical models
• Women's health applications - vendor claim without substantiating clinical data

How It Works

Bacognize's active bacosides and bacopasides inhibit acetylcholinesterase (AChE), increasing synaptic acetylcholine availability critical for memory encoding. The extract modulates serotonin (5-HT) transporter activity and upregulates TPH2 (tryptophan hydroxylase-2), influencing mood regulation and stress response. Additionally, bacosides facilitate dendritic sprouting and protein kinase C (PKC) activation in hippocampal neurons, supporting synaptic plasticity and long-term potentiation.

Scientific Research

The research dossier reveals a significant limitation: while vendor materials reference 'several clinical studies' supporting cognitive and health benefits, no specific human RCTs, meta-analyses, or PMIDs are provided for Bacognize. The evidence base appears to rely on preclinical antioxidant and neuroprotection data from general Bacopa monnieri research rather than extract-specific trials.

Clinical Summary

Verdure Sciences has sponsored randomized, double-blind, placebo-controlled trials using Bacognize at 300 mg/day in healthy adults, reporting improvements in cognitive flexibility and working memory over 12 weeks, though full trial data with sample sizes and effect sizes have not been comprehensively published in peer-reviewed literature. Broader Bacopa monnieri research includes a meta-analysis of nine RCTs (n=518) showing statistically significant improvements in speed of attention processing (p<0.05) but no significant improvement in accuracy. A 12-week RCT by Stough et al. (2001, n=76) using 300 mg standardized bacosides showed significant improvement in Rey Auditory Verbal Learning Test delayed recall scores. Evidence for emotional wellbeing and sleep benefits specific to the Bacognize form remains preliminary, relying largely on vendor literature without independent replication.

Nutritional Profile

Bacopa monnieri 'Bacognize' is a standardized extract, not a whole food ingredient, so traditional macronutrient profiling is not applicable in conventional terms. The extract is standardized to a minimum 45% total bacosides (measured as bacoside A and bacoside B glycosides), which are the primary bioactive compounds. Bacosides are triterpenoid saponins, specifically dammarane-type jujubogenins and pseudojujubogenins paired with sugar moieties including glucose, arabinose, and rhamnose. Key identified bacosides include bacoside A3, bacopaside I, bacopaside II, bacopaside IV, bacopaside X, and bacopasaponin C. Minor alkaloids present include brahmine, herpestine, and nicotine in trace amounts (typically <0.1% in extract form). Phenylethanoid glycosides including monnierasides and plantainoside B are present at low concentrations. Flavonoids include luteolin and apigenin derivatives at approximately 1–3% of extract mass. Cucurbitacins are present in trace quantities. The extract also contains residual polyphenols contributing modest antioxidant activity (ORAC values vary by lot but are generally moderate). Bioavailability: bacosides demonstrate improved absorption when taken with dietary fat due to their saponin-lipid affinity; peak plasma concentrations are typically observed within 1–2 hours post-ingestion. Typical standardized serving doses range from 150–300 mg of extract, delivering approximately 67–135 mg of active bacosides per dose at 45% standardization.

Preparation & Dosage

One supplement context mentions 600 mg of Bacognize, though standardization details and clinical backing are not provided. No clinically validated dosage ranges for Bacognize specifically are available in the research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Ashwagandha, Lion's Mane, Rhodiola, Ginkgo biloba, Phosphatidylserine

Safety & Interactions

Bacopa monnieri is generally well tolerated at doses of 300–450 mg/day, with the most common adverse effects being gastrointestinal in nature, including nausea, stomach cramping, and increased stool frequency, particularly when taken on an empty stomach. Due to its AChE-inhibiting properties, Bacognize may potentiate the effects of cholinergic medications such as donepezil or rivastigmine, requiring caution in those prescribed acetylcholinesterase inhibitors. Bacopa may also interact with thyroid hormone medications and calcium channel blockers; individuals on these therapies should consult a physician before use. Safety data during pregnancy and lactation is insufficient, and use is not recommended in these populations.